spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  hyaluronan 

 HSMN NewsFeed - 22 Jun 2021
ViiV Healthcare and Halozyme enter global collaboration and license agreement for ENHANZE(R) drug delivery technology to enable development of "ultra-long-acting" medicines for HIV
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 1 Feb 2021
Galderma Receives FDA Approval for Restylane(R) Defyne for Chin Augmentation
Devices Dermatology FDA
 HSMN NewsFeed - 14 Sep 2017
Halozyme Licenses New Enhanze Target For $30 Million Upfront Payment, Future Milestones And Royalties
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 2 Feb 2017
Zimmer Biomet Announces FDA Approval of Expanded 26-week Efficacy Claim for Gel-One(R) Cross-Linked Hyaluronate for Treatment of Pain Associated with Knee Osteoarthritis
Devices Orthopaedic FDA
 HSMN NewsFeed - 21 Jan 2016
Halozyme Announces First Clinical Dosing Of Adalimumab (Humira) Using ENHANZE(TM) Technology
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 21 Dec 2015
Halozyme Enters Into Global Collaboration And Licensing Agreement With Lilly
Biopharmaceuticals Licensing
 HSMN NewsFeed - 3 Nov 2015
Anika Therapeutics Announces Health Canada Approval of CINGAL(R) for the Treatment of Pain Associated with Osteoarthritis of the Knee
Devices Orthopaedic Regulatory
 HSMN NewsFeed - 11 Jun 2015
XTuit Pharmaceuticals Closes $22 Million Series A Financing to Advance Novel Microenvironmental Modulators for Cancers and Fibrotic Disorders
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 29 Dec 2014
BioTime Appoints Adi Mohanty Chief Operating Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 4 Nov 2014
BioTime Receives Authorization to Begin Pivotal Human Clinical Trial of Renevia(TM) in Europe
Regenerative Medicine HIV/AIDS
 HSMN NewsFeed - 16 Jul 2013
Carbylan BioSurgery, Inc. Announces Appointment of President and CEO to Lead Company Through Next Phase of Development
Devices Orthopaedic Personnel
 HSMN NewsFeed - 19 Apr 2013
BioTime Enters into Worldwide License Agreement with UCLA to Develop Therapy for the Treatment of Stroke
Regenerative Medicine Neurology Licensing
 HSMN NewsFeed - 20 Dec 2012
BioTime Announces the Appointment of Jeffrey Janus as Vice President
Regenerative Medicine Personnel
 HSMN NewsFeed - 1 Nov 2012
BioTime Subsidiary OrthoCyte Corporation Announces the Appointment of Francois Binette as Vice President
Regenerative Medicine Orthopaedic Personnel
 HSMN NewsFeed - 18 Oct 2011
Halozyme Announces Positive Results from Roche's Subcutaneous Herceptin Phase 3 Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 May 2009
Ferring Pharmaceuticals Unveils Six-Month Efficacy Data for EUFLEXXA(R) for the Treatment of Osteoarthritis Knee Pain
Biopharmaceuticals
 HSMN NewsFeed - 26 Feb 2009
FDA Approves Genzyme's Synvisc-One for Osteoarthritis of the Knee
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Jun 2008
Anika Therapeutics Announces Commercial Availability of MONOVISC(TM) in Europe
Devices Orthopaedic
 HSMN NewsFeed - 14 May 2008
Carticept Medical Reports First Patients Treated in Pivotal Study of Agilus(TM) Therapy for Pain Associated with Ankle Osteoarthritis
Biopharmaceuticals Orthopaedic
 HSMN NewsFeed - 19 Dec 2007
Genzyme Receives European CE Mark for Single-Treatment Synvisc-One(TM)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 7 Nov 2007
Cost-Effectiveness Study Supports Use of EUFLEXXA(TM) by Rheumatologists for Pain Relief in Patients with Knee Osteoarthritis
Biopharmaceuticals
 HSMN NewsFeed - 20 Jun 2007
Genzyme Files for Approval of Single-Treatment Synvisc-One(TM)
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Apr 2007
Lifecore Biomedical Announces License Agreement
Biopharmaceuticals Licensing
 HSMN NewsFeed - 2 Oct 2006
Genzyme Receives European Approval for Synvisc(R) In Ankle and Shoulder Osteoarthritis Indications
Biopharmaceuticals Orthopaedic Regulatory
 HSMN NewsFeed - 11 Aug 2006
Genzyme Files for European Approval of Synvisc(R) In Ankle and Shoulder Indications
Biopharmaceuticals Orthopaedic Regulatory
 HSMN NewsFeed - 23 Jun 2006
Positive Synvisc Data Presented at European Conference
Biopharmaceuticals
 HSMN NewsFeed - 20 Jun 2006
Lifecore Names Martin J. Emerson to Board of Directors
Devices Surgery Personnel
 HSMN NewsFeed - 9 Mar 2006
Smith & Nephew Announces FDA Approval of an Amended Label for SUPARTZ(R) Joint Fluid Therapy
Biopharmaceuticals Orthopaedic FDA
 HSMN NewsFeed - 13 Feb 2006
Head-to-Head Study Shows EUFLEXXA(TM) Has Greater Tolerability Compared to Synvisc(R) for Osteoarthritis Knee Pain
Biopharmaceuticals Orthopaedic
Return to NewsFeed  

 Additional items found! 15

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 15 additional stories matching:
hyaluronan
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.